Cargando…
Tacrolimus Combined with Corticosteroids Improved the Outcome of CIDP Patients with Autoantibodies Against Paranodal Proteins
PURPOSE: To investigate the response of tacrolimus to chronic inflammatory demyelinating polyneuropathy (CIDP) with autoantibodies against paranodal proteins, including neurofascin-155 (NF155), contactin-1 (CNTN1) and contactin-associated protein 1 (Caspr1). METHODS: We retrospectively reviewed all...
Autores principales: | Yang, Meng-ge, Xu, Li, Ji, Suqiong, Gao, Huajie, Zhang, Qing, Bu, Bitao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208735/ https://www.ncbi.nlm.nih.gov/pubmed/35734550 http://dx.doi.org/10.2147/NDT.S361461 |
Ejemplares similares
-
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins
por: Querol, Luis, et al.
Publicado: (2015) -
Efficacy of tacrolimus as long-term immunotherapy for neuronal
surface antibody-mediated autoimmune encephalitis
por: Liu, Chenchen, et al.
Publicado: (2022) -
Remission and relapses of myasthenia gravis on long-term tacrolimus:
a retrospective cross-sectional study of a Chinese cohort
por: Bi, Zhuajin, et al.
Publicado: (2022) -
The Clinicopathological Distinction between Immune-Mediated Necrotizing Myopathy and Limb–Girdle Muscular Dystrophy R2: Key Points to Prevent Misdiagnosis
por: Yang, Mengge, et al.
Publicado: (2022) -
Overlapping syndrome mimicking infectious meningoencephalitis in a patient with MOG and GFAP IgG
por: Ji, Suqiong, et al.
Publicado: (2021)